Arno Therapeutics, Inc Research and Development Expense
Arno Therapeutics, Inc reported Research and Development Expense of $1.12 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2016-11-14
- Arno Therapeutics, Inc research and development expense for the quarter ending 2016-09-30 was $1.12M, a 37.77% decline year-over-year.
- Arno Therapeutics, Inc research and development expense for the quarter ending 2016-06-30 was $2.06M, a 22.34% decline year-over-year.
- Arno Therapeutics, Inc research and development expense for the quarter ending 2016-03-31 was $1.54M, a 37.60% decline year-over-year.
- Arno Therapeutics, Inc research and development expense for the quarter ending 2015-12-31 was $1.74M, a 32.28% decline year-over-year.
- Arno Therapeutics, Inc research and development expense for fiscal 2015 was $8.65M, a 41.69% decline from fiscal 2014.
- Arno Therapeutics, Inc research and development expense for fiscal 2014 was $14.84M, a 10.12% increase from fiscal 2013.
- Arno Therapeutics, Inc research and development expense for fiscal 2013 was $13.48M, a 57.86% increase from fiscal 2012.
- Arno Therapeutics, Inc research and development expense for fiscal 2012 was $8.54M, a 50.02% increase from fiscal 2011.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 71 month | Research and Development Expense 74 month | Research and Development Expense 77 month | Research and Development Expense 80 month | Research and Development Expense 83 month | Research and Development Expense 86 month | Research and Development Expense 89 month | Research and Development Expense 92 month | Research and Development Expense 95 month | Research and Development Expense 98 month | Research and Development Expense 101 month | Research and Development Expense 104 month | Research and Development Expense 107 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $1.12M 10-Q · filed 2016-11-14 | $3.17M derived: sum of 2 quarters · filed 2016-11-14 | $4.72M 10-Q · filed 2016-11-14 | $6.45M derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||
| 2016-06-30 | $2.06M 10-Q · filed 2016-08-22 | $3.60M 10-Q · filed 2016-08-22 | $5.34M derived: sum of 3 quarters · filed 2016-08-22 | $7.13M derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||
| 2016-03-31 | $1.54M 10-Q · filed 2016-05-16 | $3.28M derived: sum of 2 quarters · filed 2016-05-16 | $5.07M derived: sum of 3 quarters · filed 2016-11-14 | $7.72M derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||
| 2015-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $3.53M derived: sum of 2 quarters · filed 2016-11-14 | $6.18M derived: sum of 3 quarters · filed 2016-11-14 | $8.65M 10-K · filed 2016-03-30 | |||||||||||||
| 2015-09-30 | $1.79M 10-Q · filed 2016-11-14 | $4.44M derived: sum of 2 quarters · filed 2016-11-14 | $6.92M 10-Q · filed 2016-11-14 | $9.48M derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||
| 2015-06-30 | $2.65M 10-Q · filed 2016-08-22 | $5.12M 10-Q · filed 2016-08-22 | $7.69M derived: sum of 3 quarters · filed 2016-08-22 | $11.44M derived: sum of 4 quarters · filed 2016-08-22 | |||||||||||||
| 2015-03-31 | $2.47M 10-Q · filed 2016-05-16 | $5.04M derived: sum of 2 quarters · filed 2016-05-16 | $8.80M derived: sum of 3 quarters · filed 2016-05-16 | $12.88M derived: sum of 4 quarters · filed 2016-05-16 | |||||||||||||
| 2014-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $6.32M derived: sum of 2 quarters · filed 2016-03-30 | $10.41M derived: sum of 3 quarters · filed 2016-03-30 | $14.84M 10-K · filed 2016-03-30 | |||||||||||||
| 2014-09-30 | $3.76M 10-Q · filed 2015-11-16 | $7.84M derived: sum of 2 quarters · filed 2015-11-16 | $12.27M 10-Q · filed 2015-11-16 | $16.85M derived: sum of 4 quarters · filed 2015-11-16 | |||||||||||||
| 2014-06-30 | $4.08M 10-Q · filed 2015-08-14 | $8.52M 10-Q · filed 2015-08-14 | $13.09M derived: sum of 3 quarters · filed 2015-08-14 | $16.26M derived: sum of 4 quarters · filed 2015-08-14 | $58.84M 10-Q · filed 2014-08-14 | ||||||||||||
| 2014-03-31 | $4.43M 10-Q · filed 2015-05-15 | $9.01M derived: sum of 2 quarters · filed 2015-05-15 | $12.18M derived: sum of 3 quarters · filed 2015-05-15 | $14.92M derived: sum of 4 quarters · filed 2015-05-15 | $54.76M 10-Q · filed 2014-05-15 | ||||||||||||
| 2013-12-31 | $4.57M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $7.74M derived: sum of 2 quarters · filed 2015-03-31 | $10.48M derived: sum of 3 quarters · filed 2015-03-31 | $13.48M 10-K · filed 2015-03-31 | $50.32M 10-K · filed 2014-03-31 | ||||||||||||
| 2013-09-30 | $3.17M 10-Q · filed 2014-11-14 | $5.91M derived: sum of 2 quarters · filed 2014-11-14 | $8.90M 10-Q · filed 2014-11-14 | $11.15M derived: sum of 4 quarters · filed 2014-11-14 | $45.75M 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | $2.74M 10-Q · filed 2014-08-14 | $5.73M 10-Q · filed 2014-08-14 | $7.99M derived: sum of 3 quarters · filed 2014-08-14 | $10.05M derived: sum of 4 quarters · filed 2014-08-14 | $42.58M 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $2.99M 10-Q · filed 2014-05-15 | $5.24M derived: sum of 2 quarters · filed 2014-05-15 | $7.31M derived: sum of 3 quarters · filed 2014-05-15 | $9.65M derived: sum of 4 quarters · filed 2014-05-15 | $39.84M 10-Q · filed 2013-05-15 | ||||||||||||
| 2012-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $4.32M derived: sum of 2 quarters · filed 2014-03-31 | $6.66M derived: sum of 3 quarters · filed 2014-03-31 | $8.54M 10-K · filed 2014-03-31 | $36.85M 10-K · filed 2013-04-01 | ||||||||||||
| 2012-09-30 | $2.07M 10-Q · filed 2013-11-14 | $4.41M derived: sum of 2 quarters · filed 2013-08-14 | $6.29M 10-Q · filed 2013-11-14 | $7.98M derived: sum of 4 quarters · filed 2013-08-14 | $34.59M 10-Q · filed 2012-11-19 | ||||||||||||
| 2012-06-30 | $2.34M 10-Q · filed 2013-08-14 | $4.22M 10-Q · filed 2013-08-14 | $5.91M derived: sum of 3 quarters · filed 2013-08-14 | $7.33M derived: sum of 4 quarters · filed 2013-08-14 | $32.53M 10-Q/A · filed 2012-09-07 | ||||||||||||
| 2012-03-31 | $1.88M 10-Q · filed 2013-05-15 | $3.57M derived: sum of 2 quarters · filed 2013-05-15 | $4.99M derived: sum of 3 quarters · filed 2013-05-15 | $6.30M derived: sum of 4 quarters · filed 2013-05-15 | $30.19M 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $3.11M derived: sum of 2 quarters · filed 2013-04-01 | $4.42M derived: sum of 3 quarters · filed 2013-04-01 | $5.69M 10-K · filed 2013-04-01 | $28.31M 10-K · filed 2012-03-30 | ||||||||||||
| 2011-09-30 | $1.42M 10-Q · filed 2012-11-19 | $2.73M derived: sum of 2 quarters · filed 2012-11-19 | $4.00M 10-Q · filed 2012-11-19 | $5.08M derived: sum of 4 quarters · filed 2012-11-19 | $26.62M 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | $1.31M 10-Q/A · filed 2012-09-07 | $2.58M 10-Q/A · filed 2012-09-07 | $3.66M derived: sum of 3 quarters · filed 2012-09-07 | $4.59M derived: sum of 4 quarters · filed 2012-09-07 | $25.19M 10-Q · filed 2011-08-15 | ||||||||||||
| 2011-03-31 | $1.27M 10-Q · filed 2012-05-15 | $2.35M derived: sum of 2 quarters · filed 2012-05-15 | $3.28M derived: sum of 3 quarters · filed 2012-05-15 | $4.34M derived: sum of 4 quarters · filed 2012-05-15 | |||||||||||||
| 2010-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $2.01M derived: sum of 2 quarters · filed 2012-03-30 | $3.08M derived: sum of 3 quarters · filed 2012-03-30 | $4.14M 10-K · filed 2012-03-30 | |||||||||||||
| 2010-09-30 | $927.89K 10-Q · filed 2011-11-14 | $2.00M derived: sum of 2 quarters · filed 2011-11-14 | $3.06M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2010-06-30 | $1.07M 10-Q · filed 2011-08-15 | $2.13M 10-Q · filed 2011-08-15 |